Therapeutic dosing with the ST2-Fc fusion protein had no effect on BLM-induced fibrosis as assessed by lung hydroxyproline levels (Fig. 4B), lung morphology and collagen deposition in the lungs (Fig. 4C & 4D). The gene discussed is IL1RL1; the disease is fibrosis.